Birt-Hogg-Dubé syndrome: Clinical and molecular aspects of recently identified kidney cancer syndrome
- PMID: 26608100
- DOI: 10.1111/iju.13015
Birt-Hogg-Dubé syndrome: Clinical and molecular aspects of recently identified kidney cancer syndrome
Abstract
Birt-Hogg-Dubé syndrome is an autosomal dominantly inherited disease that predisposes patients to develop fibrofolliculoma, lung cysts and bilateral multifocal renal tumors, histologically hybrid oncocytic/chromophobe tumors, chromophobe renal cell carcinoma, oncocytoma, papillary renal cell carcinoma and clear cell renal cell carcinoma. The predominant forms of Birt-Hogg-Dubé syndrome-associated renal tumors, hybrid oncocytic/chromophobe tumors and chromophobe renal cell carcinoma are typically less aggressive, and a therapeutic principle for these tumors is a surgical removal with nephron-sparing. The timing of surgery is the most critical element for postoperative renal function, which is one of the important prognostic factors for Birt-Hogg-Dubé syndrome patients. The folliculin gene (FLCN) that is responsible for Birt-Hogg-Dubé syndrome was isolated as a novel tumor suppressor for kidney cancer. Recent studies using murine models for FLCN, a protein encoded by the FLCN gene, and its two binding partners, folliculin-interacting protein 1 (FNIP1) and folliculin-interacting protein 2 (FNIP2), have uncovered important roles for FLCN, FNIP1 and FNIP2 in cell metabolism, which include AMP-activated protein kinase-mediated energy sensing, Ppargc1a-driven mitochondrial oxidative phosphorylation and mTORC1-dependent cell proliferation. Birt-Hogg-Dubé syndrome is a hereditary hamartoma syndrome, which is triggered by metabolic alterations under a functional loss of FLCN/FNIP1/FNIP2 complex, a critical regulator of kidney cell proliferation rate; a mechanistic insight into the FLCN/FNIP1/FNIP2 pathway could provide us a basis for developing new therapeutics for kidney cancer.
Keywords: Birt-Hogg-Dubé syndrome; folliculin; kidney cancer; mTORC1; mitochondria.
© 2015 The Japanese Urological Association.
Similar articles
-
Nutrient-induced FNIP degradation by SCFβ-TRCP regulates FLCN complex localization and promotes renal cancer progression.Oncotarget. 2017 Feb 7;8(6):9947-9960. doi: 10.18632/oncotarget.14221. Oncotarget. 2017. PMID: 28039480 Free PMC article.
-
Folliculin-interacting proteins Fnip1 and Fnip2 play critical roles in kidney tumor suppression in cooperation with Flcn.Proc Natl Acad Sci U S A. 2015 Mar 31;112(13):E1624-31. doi: 10.1073/pnas.1419502112. Epub 2015 Mar 16. Proc Natl Acad Sci U S A. 2015. PMID: 25775561 Free PMC article.
-
Interaction of folliculin (Birt-Hogg-Dubé gene product) with a novel Fnip1-like (FnipL/Fnip2) protein.Oncogene. 2008 Sep 11;27(40):5339-47. doi: 10.1038/onc.2008.261. Epub 2008 Jul 28. Oncogene. 2008. PMID: 18663353
-
FLCN: The causative gene for Birt-Hogg-Dubé syndrome.Gene. 2018 Jan 15;640:28-42. doi: 10.1016/j.gene.2017.09.044. Epub 2017 Sep 29. Gene. 2018. PMID: 28970150 Free PMC article. Review.
-
Review of renal tumors associated with Birt-Hogg-Dubé syndrome with focus on clinical and pathobiological aspects.Pol J Pathol. 2014 Jun;65(2):93-9. doi: 10.5114/pjp.2014.43958. Pol J Pathol. 2014. PMID: 25119168 Review.
Cited by
-
Urticarial vasculitis and systemic symptoms as initial presentation of Birt-Hogg-Dubé syndrome: A case report.SAGE Open Med Case Rep. 2024 May 26;12:2050313X241251759. doi: 10.1177/2050313X241251759. eCollection 2024. SAGE Open Med Case Rep. 2024. PMID: 38803360 Free PMC article.
-
Hybrid Oncocytic Tumors (HOTs) in Birt-Hogg-Dubé Syndrome Patients-A Tale of Two Cities: Sequencing Analysis Reveals Dual Lineage Markers Capturing the 2 Cellular Populations of HOT.Am J Surg Pathol. 2024 Feb 1;48(2):163-173. doi: 10.1097/PAS.0000000000002152. Epub 2023 Nov 24. Am J Surg Pathol. 2024. PMID: 37994665 Free PMC article.
-
A case of ipsilateral three simultaneous renal cell carcinomas with different histologic types.IJU Case Rep. 2023 Sep 4;6(6):410-414. doi: 10.1002/iju5.12636. eCollection 2023 Nov. IJU Case Rep. 2023. PMID: 37928302 Free PMC article.
-
Birt-Hogg-Dubé Syndrome: Two Patients With Different Initial Presentations.Cureus. 2022 Oct 22;14(10):e30578. doi: 10.7759/cureus.30578. eCollection 2022 Oct. Cureus. 2022. PMID: 36348850 Free PMC article.
-
Percutaneous Thermal Ablation for Renal Tumors in Patients with Birt-Hogg-Dubé Syndrome.Cancers (Basel). 2022 Oct 11;14(20):4969. doi: 10.3390/cancers14204969. Cancers (Basel). 2022. PMID: 36291753 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials